Gene Editing Market Size

Gene Editing Market Size

Gene Editing Market size surpassed USD 5.4 Bn in 2021 and is expected to witness a 15.5% CAGR from 2022 to 2030 owing to an increasing technological advancement driven by the rapidly evolving CRISPR technology with its wide range of applications for gene editing.

To get key market trends

  Download Free Sample

This technology is mainly used to gain accessibility of genetically modified crops by delivering gene editing reagents in the plants. Moreover, this technology is also accessible for genetically modified animals with application for agricultural purposes and biomedical fields.

The impact of COVID-19 on the gene editing market share is observed to be positive. Recently, in 2020, SHERLOCK CRISPR SARS-CoV-2 test kit was granted by Emergency Use Authorization from the FDA. This is due to the programming by CRISPR for detecting genetic pattern of SARS-CoV-2 by utilising gRNA. In case target is detected in a sample, the CRISPR is activated and released.

Gene Editing or genome editing is mainly used to change an organism’s DNA by various group of technologies. This method allows genetic material to be replaced, added, or removed at spotted locations in the genome. Therefore, various editing approaches have been developed for its application in the industry. Gene editing is also used for prevention and treatment of human diseases such as cystic fibrosis, sickle cell diseases, HIV infection, cancer, and others.